Status:

COMPLETED

A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)

Lead Sponsor:

Merck Sharp & Dohme LLC

Collaborating Sponsors:

Federal University of São Paulo

Conditions:

Candidemia

Eligibility:

All Genders

Brief Summary

This study will evaluate the incidence rate of Candida blood stream infection (candidemia) among people hospitalized in participating medical centers in Brazil, and will assess the antifungal drug sus...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Hospitalized in a participating medical center
  • Developed candidemia blood stream infection (confirmed by isolation of Candida species from blood culture)

Exclusion

    Key Trial Info

    Start Date :

    April 1 2010

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2012

    Estimated Enrollment :

    436 Patients enrolled

    Trial Details

    Trial ID

    NCT01174147

    Start Date

    April 1 2010

    End Date

    November 1 2012

    Last Update

    October 13 2016

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093) | DecenTrialz